Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Teoxane SA holds a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. There is 1 pending office action for this portfolio. This matter is assigned to 1 distinct examiner and 1 distinct art unit.
The busiest examiner is MILLER, DALE R, who has 1 busiest examiner pending office action. This matches the 1 pending office action total. The prosecution is currently very narrow, focusing on a single pharmaceutical application.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MILLER, DALE R | 1 | 62.5% | +17.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18025317 | HYDROGEL COMPRISING A CROSS-LINKED AND SILYLATED POLYSACCHARIDE AND PROCESS FOR OBTAINING SAME | MILLER, DALE R | — |
| Art Unit | Apps |
|---|---|
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18025317 | HYDROGEL COMPRISING A CROSS-LINKED AND SILYLATED POLYSACCHARIDE AND PROCESS FOR OBTAINING SAME | MILLER, DALE R | 1693 | §103DP | Final Rejection | — | Pending | Mar 08, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTeoxane SA has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Dale R Miller has the most, with 1 of Teoxane SA's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
